{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/short-run-small-window-drug-manufacture-clinical-research-unit-cru#webpage",
"url": "https://www.fortrea.com/insights/short-run-small-window-drug-manufacture-clinical-research-unit-cru",
"name": "Short-run, small window drug manufacture at the clinical research unit (CRU).",
"description": "Explore this Fortrea white paper on short-run small-windowed drug manufacture in clinical research units and discover how rapid, flexible manufacturing approaches are supporting investigational product production and early-phase clinical development programs. The white paper examines key considerations in clinical research unit manufacturing, including short-run drug manufacture, small-windowed manufacturing timelines, investigational medicinal product production, GMP clinical manufacturing processes, GMP clean manufacturing environments, and efficient early-phase clinical trial supply planning. Learn how integrated CRU manufacturing support, compliant manufacturing readiness, accelerated production workflows, cleanroom manufacturing environments, rapid clinical supply coordination, and streamlined manufacturing strategies are helping organizations improve clinical trial readiness, support flexible development timelines, strengthen manufacturing compliance, and optimize investigational product manufacturing for early-stage clinical research programs.."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Short-run, small window drug manufacture at the clinical research unit (CRU).",
"item": "https://www.fortrea.com/insights/short-run-small-window-drug-manufacture-clinical-research-unit-cru"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/short-run-small-window-drug-manufacture-clinical-research-unit-cru#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/short-run-small-window-drug-manufacture-clinical-research-unit-cru#webpage"
},
"headline": "Short-Run Small-Windowed Drug Manufacture in Clinical Research Units | Fortrea White Paper",
"description": "Explore this Fortrea white paper on short-run small-windowed drug manufacture in clinical research units and discover how rapid, flexible manufacturing approaches are supporting investigational product production and early-phase clinical development programs. The white paper examines key considerations in clinical research unit manufacturing, including short-run drug manufacture, small-windowed manufacturing timelines, investigational medicinal product production, GMP clinical manufacturing processes, GMP clean manufacturing environments, and efficient early-phase clinical trial supply planning. Learn how integrated CRU manufacturing support, compliant manufacturing readiness, accelerated production workflows, cleanroom manufacturing environments, rapid clinical supply coordination, and streamlined manufacturing strategies are helping organizations improve clinical trial readiness, support flexible development timelines, strengthen manufacturing compliance, and optimize investigational product manufacturing for early-stage clinical research programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-11-26",
"dateModified": "2025-11-26",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/drug-manufacture-at-cru.pdf",
"encodingFormat": "application/pdf"
}
}
]
}